UNE Professor's Breast Cancer Biomarker Receives a Patent - NECN
Maine

Maine

The latest news from around the state

UNE Professor's Breast Cancer Biomarker Receives a Patent

    processing...

    NEWSLETTERS

    UNE Professor's Breast Cancer Biomarker Receives a Patent

    A University of New England pharmacy professor has received a patent for an innovation in the early detection of breast cancer.

    Srinidi Mohan's research focuses on a blood marker that can be used to detect the presence of highly aggressive tumors. He says the marker is a reliable indicator for estrogen receptor-negative tumors, the most aggressive types of breast cancer.

    Mohan said Wednesday the bio-marker screening could represent a cost-effective option for early detection, monitoring disease progression, measuring treatment outcomes and providing monthly check-ups.

    The American Breast Cancer Foundation says about 60,000 women are diagnosed with those tumors each year. They're most prevalent among young women and in African-American women. Chemotherapy is the common treatment for the deadly tumors.

    Trump Celebrates Mueller Report as Democrats Plan Next Step

    [NATL] Trump Celebrates Mueller Report as Democrat Lawmakers Plan Next Step

    President Donald Trump celebrated the release of Special Counsel Robert Mueller's report into Russia collusion today, but Democrats say this story isn't over and are already talking about their next step. The report, which totals over 400 pages, neither condemns nor exonerates the president.

    (Published Thursday, April 18, 2019)

    Get the latest from necn anywhere, anytime

    • Download the App

      Available for IOS and Android